Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Feed excerpt — reported by TechCrunch

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at TechCrunch →

View MAP Context →